"Context--The Women's Health Initiative (WHI) trial of estrogen plus progestin vs. placebo was stopped early, after a mean 5.6 years of follow-up, because the overall health risks of hormone therapy exceeded its benefits.

"Objective--To report health outcomes at 3 years...after the intervention was stopped...

"Conclusions--...A greater risk of fatal and nonfatal malignancies occurred after intervention in the (treatment group)"
Emphases added.

From: Journal of the A.M.A., vol. 299, 2008. By: Drs. Heiss, Wallace, Stefanick, et al, U. of N. Carolina, U. of Iowa, Fred Hutchinson Cancer Res. Ctr., U. of Texas Health Science Ctr., Harbor-UCLA Med. Ctr., U. of Cinn., Brigham & Women's Hosp., Harvard Med. School, Nat'l. Heart, Lung, and Blood Inst., and Stanford Prevention Res. Ctr.

Our editor's comment, "Soy beans, anyone?"

The health information in this web site is for educational purposes only and is not providing medical or professional advice. It should not be used for diagnosing or treating a health problem or disease. It is not a substitute for professional medical care. If you have or suspect you might have any health problems, you should consult a physician.

Copyright Health Bulletin 2010 | This site is 100% owned by C.A. Inc.
Edited by William A. Kent, independent researcher, author and lecturer, who has studied health and nutrition for over 35 years. All information gathered from the leading medical and scientific journals of the world. The TRUTH, not opinions or sales pitches. Nothing in this website may be reprinted, re-used or quoted or any part thereof for commercial purposes.

Website Design and Updates by Monica's Website Design